Opus Fund Services Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Finance

Industry

Estimated Revenue & Valuation

  • Opus Fund Services's estimated annual revenue is currently $62.8M per year.(i)
  • Opus Fund Services's estimated revenue per employee is $231,000

Employee Data

  • Opus Fund Services has 272 Employees.(i)
  • Opus Fund Services grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6390M24960-1%N/A$27.7B
#2
$489.8M16666%N/AN/A
#3
$16.2M77-15%N/AN/A
Add Company

Opus Fund Services was established in 2006 and is a leading independent and privately owned full service fund administration company providing automated, integrated middle and back office administration services to hedge funds and asset management firms. In 2012 Opus was named Best Overall Administrator for Client Service at the HFMWeek Awards, and “Top Ranked” fund administrator by Global Custodian for an unprecedented third year in a row. Opus Fund Services has offices in Bermuda, Chicago, Naperville and San Francisco. Opus Fund Services (Bermuda) Ltd. Is licensed by the Bermuda Monetary Authority under the Investment Funds Act 2006

keywords:N/A

N/A

Total Funding

272

Number of Employees

$62.8M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Opus Fund Services's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Information OfficerReveal Email/Phone
3
Business DevelopmentReveal Email/Phone
4
COOReveal Email/Phone
5
Chief Integration OfficerReveal Email/Phone
6
COOReveal Email/Phone
7
Sr. Fund Accountant/Account ManagerReveal Email/Phone
8
Technology Solutions ManagerReveal Email/Phone
9
Director, Business DevelopmentReveal Email/Phone
10
VPReveal Email/Phone

Opus Fund Services News

2022-04-06 - Opus Enters Collaboration with Resilience for AAV-Based Gene ...

Opus Genetics, a gene therapy company focused on inherited retinal ... and good manufacturing practice manufacturing services for Opus'...

2022-04-06 - Opus Enters Strategic Collaboration with Resilience for AAV-based Gene Therapy Development and Manufacturing for Inherited Retinal Diseases

Resilience will provide process and analytical development, quality control testing, and GMP manufacturing services for IND-enabling toxicology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$76.5M27734%N/A
#2
$35M2975%N/A
#3
$79M3012%N/A
#4
$37.8M302-4%N/A
#5
$75M306N/AN/A